Citalopram for Agitation in Alzheimer's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Alzheimer's DiseaseAgitation
Interventions
DRUG

citalopram

target dose 30mg daily for 9 weeks

DRUG

placebo

daily for 9 weeks

Trial Locations (8)

10032

Columbia University, New York

14559

Monroe Community Hospital, Rochester

19104

University of Pennsylvania, Section of Geriatric Psychiatry, Ralston House, Philadelphia

21224

Johns Hopkins University, Baltimore

29406

Medical University of South Carolina Alzheimer's Research and Clinical Programs, Charleston

90089

University of Southern California Keck School of Medicine Memory and Aging Center, Los Angeles

94304

VA Palo Alto Health Care System, Palo Alto

M6J1H4

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

JHSPH Center for Clinical Trials

OTHER